Member News
-
Awakn Life Sciences’ Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs
Phase III Trial to Cost approximately CA$3.75 million with Awakn’s contribution expected to be approximately CA$1.25 million, Marks…
-
American Rare Earths Limited: June 2022 Quarterly Activities Report
209220720-June-Quarterly-Activities-Report-.pdf
-
Sixth Wave Updates on Affinity(TM) System Installation Schedule
July 19, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Power Nickel Releases Initial NI 43-101 Compliant Mineral Resource Estimate on the Nisk Project
More than 2.5 Million Indicated Tonnes at 1.20 %NiEq and 1.4 Million Inferred Tonnes at 1.29 %NiEq July…
-
Moovly Partners With DAM Solution Provider Widen to Offer Enterprises Brand-Aligned Video Creation Solutions
July 19, 2022 (Source) – Moovly Media Inc. (TSXV: MVY) (OTCQB: MVVYF) (FSE: 0PV2) (“Moovly” or the “Company”) is…
-
Zentek Files a Provisional Patent on the use of ZenGUARD(TM) as an Anti-Inflammatory Agent
July 18, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has…
-
Awakn Life Sciences Provides a Business and Corporate Update
July 15, 2022 (Source) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology…
-
Nano One Annual General Meeting and Investor Update
July 14, 2022 (Source) – Nano One® Materials Corp. (“Nano One”), a clean technology company with patented processes for…
